Nonhormonal pharmacologic and complementary treatment of menopause

Clinics in Family Practice

Volumn 4, Issue 1, 2002, Pages 155-171

  Thiedke, C Carolyn ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCITONIN; CHOLESTIN; CLONIDINE; COMBIOPATCH; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; FISH OIL; FLUORIDE SODIUM; GABAPENTIN; IPRIFLAVONE; MEDROXYPROGESTERONE; NORETHISTERONE; OXYBUTYNIN; PHYTOESTROGEN; PIPERAZINE ESTRONE SULFATE; PRASTERONE; PROGESTERONE; PROGESTERONE DERIVATIVE; PROPRANOLOL; PSEUDOEPHEDRINE; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TOLTERODINE; UNINDEXED DRUG; VENLAFAXINE; VITAMIN D; VITAMIN K GROUP;

ARTICLE; CONTROLLED STUDY; DIET THERAPY; DROWSINESS; EXERCISE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MENOPAUSE; OSTEOPOROSIS; URINE INCONTINENCE; XEROSTOMIA;

EID: 0036221721     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(03)00056-4     Document Type: Review

References (86)

1. Effect of garlic and fish oil supplementation on serum lipid and lipoprotein concentration in hypercholesterolemic men
2. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal bone loss
3. Ipriflavone in the treatment of postmenopausal osteoporosis: A randomized control trial
4. Meta-analysis of the effects of soy protein intake on serum lipids
5. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: A paradox
6. Making the most of cholesterol-lowering margarines
7. Increase in femoral bone density in young women following high-impact exercise
8. Coronary artery disease prevention: What's different for women?
9. Phytoestrogens: Where are we now?
10. Importance of ω-3 fatty acids in health and disease
11. Should a doctor prescribe hormone replacement therapy which has been manufactured from mare's urine?
12. Urinary incontinence in women: Evaluation and management
13. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women
14. Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women
15. Oral micronized progesterone
16. Vitamin K intake and hip fractures in women: A prospective study
17. Behavioral treatment of menopausal hot flashes: Evaluated by ambulatory monitoring
18. Managing menopausal symptoms in breast cancer survivors: Results of a randomized control trial
19. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass
20. Nonhormonal agents show promise against hot flashes
21. Coenzyme Q10: A new drug for cardiovascular disease
22. Postmenopausal estrogen and progestin use and risk of cardiovascular disease
23. Gabapentin's effect on hot flashes and hypothermia
24. Women's Health series: Herbs of general interest to women
25. Menopause
26. Decreased mortality in users of estrogen replacement therapy
27. The roles of exercise and fall risk reduction in the prevention of osteoporosis
28. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection
29. Hip fracture rates in Hong Kong and the United States, 1988 through 1989
30. Heart and Estrogen/progestin Replacement Study (HERS) Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
31. Physical exercise and vasomotor symptoms in postmenopausal women
32. Effects of Coenzyme Q10 on exercise tolerance in chronic stable angina
33. The seven countries study: 2,289 deaths in 15 years
34. Cereals, legumes, and chronic disease risk reduction: Evidence from epidemiologic studies
35. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
36. Sexual dysfunction in the United States: Prevalence and predictors
37. The effects of progressive resistance training on bone density: A review
38. What Your Doctor May Not Tell You about Menopause
39. Pathophysiological consideration in the treatment of menopausal patients with oestrogen: The role of oestriol in the prevention of mammary carcinoma
40. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer
41. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors
42. Serum folate and cardiovascular disease mortality among US men and women
43. Alternatives to estrogen replacement therapy
44. Differentiating between natural progesterone and synthetic progestins: Clinical implication for premenstrual syndrome and perimenopause management
45. Alternatives to estrogen for menopausal symptoms
46. Alternative therapies: Part II. Congestive heart failure and hypercholesterolemia
47. Comparative study: Replens vs. local estrogen in menopausal women
48. Osteoporosis Prevention, Diagnosis, and Therapy
49. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures
50. The cholesterol-lowering action of plant stanol esters
51. Menopause
52. Lifestyle changes for coronary artery disease: What to tell patients
53. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: A prospective population-based study
54. Review: Coenzyme Q10 in health and disease
55. Oestriol with oestradiol alone: A comparison of endometrial, symptomatic, and psychological effects
56. Update on vitamin supplements for the prevention of coronary disease and stroke
57. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters
58. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
59. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes
60. The role of calcium and vitamin D in the prevention of osteoporosis
61. Prevalence of sexual dysfunction in women: Results of a study of 329 women in an outpatient gynecology clinic
62. Oral phentolamine and female sexual arousal disorder: A pilot study
63. Tolterodine use for symptoms of overactive bladder
64. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group
65. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: A multicenter, placebo-controlled trial
66. Diet, serum cholesterol and death from coronary heart disease: The Western Electric study
67. Androgen enhances sexual motivation in women: A prospective, cross over study of sex steroid administration in the surgical menopause
68. Randomized, double-blind placebo-controlled trial of Coenzyme Q10 in patients with acute MI
69. Osteoporosis: Part II. Nonpharmacologic and pharmacologic treatment
70. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow up from the Nurses Health Study
71. Vitamin E consumption and the risk of coronary disease in women
72. Garlic for the treatment of hypercholesterolemia: A meta analysis of randomized controlled trials
73. Stress incontinence: Conservative therapy with sympathomimetic drugs
74. Alternatives to conventional hormone replacement therapy
75. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women
76. Soy isoflavones: Are they useful in menopause?
77. Hormone-modulating herbs: Implications for womens health
78. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
79. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: Human and animal studies
80. Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigation